Does FARLETUZUMAB Cause Thrombocytopenia? 15 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Thrombocytopenia have been filed in association with FARLETUZUMAB. This represents 48.4% of all adverse event reports for FARLETUZUMAB.
15
Reports of Thrombocytopenia with FARLETUZUMAB
48.4%
of all FARLETUZUMAB reports
0
Deaths
13
Hospitalizations
How Dangerous Is Thrombocytopenia From FARLETUZUMAB?
Of the 15 reports, 13 (86.7%) required hospitalization.
Is Thrombocytopenia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FARLETUZUMAB. However, 15 reports have been filed with the FAERS database.
What Other Side Effects Does FARLETUZUMAB Cause?
Anaemia (7)
Febrile neutropenia (7)
Anal haemorrhage (6)
Anal incontinence (6)
Frequent bowel movements (6)
White blood cell count decreased (6)
Acute kidney injury (5)
Hyperkalaemia (5)
Small intestinal obstruction (5)
Urinary tract infection (5)
What Other Drugs Cause Thrombocytopenia?
DEXAMETHASONE (5,873)
RITUXIMAB (4,810)
CYCLOPHOSPHAMIDE (4,669)
LENALIDOMIDE (4,584)
CARBOPLATIN (4,483)
METHOTREXATE (3,865)
DOXORUBICIN (3,638)
ETOPOSIDE (3,085)
VINCRISTINE (2,940)
OXALIPLATIN (2,886)